Autophagy Determines Efficiency of Liver-Directed Gene Therapy With Adeno-Associated Viral Vectors

被引:37
|
作者
Hoesel, Marianna [1 ,2 ]
Huber, Anke [1 ,2 ]
Bohlen, Susanne [3 ]
Lucifora, Julie [4 ]
Ronzitti, Giuseppe [5 ,6 ]
Puzzo, Francesco [5 ,6 ]
Boisgerault, Florence [5 ,6 ]
Hacker, Ulrich T. [7 ]
Kwanten, Wilhelmus J. [8 ]
Kloeting, Nora [9 ]
Blueher, Matthias [10 ]
Gluschko, Alexander [1 ,3 ]
Schramm, Michael [1 ,3 ]
Utermoehlen, Olaf [1 ,3 ]
Bloch, Wilhelm [11 ]
Mingozzi, Federico [5 ,6 ,12 ]
Krut, Oleg [3 ]
Buening, Hildegard [1 ,2 ,13 ]
机构
[1] Univ Cologne, CMMC, Cologne, Germany
[2] German Ctr Infect Res DZIF, Partner Sites Bonn Cologne & Hannover Braunschwei, Braunschweig, Germany
[3] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany
[4] Univ Lyon, CRCL, INSERM, U1052, Lyon, France
[5] Genethon, Evry, France
[6] INSERM, U951, Evry, France
[7] Univ Med Leipzig, UCCL, Leipzig, Germany
[8] Univ Antwerp, LEMP, Antwerp, Belgium
[9] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany
[10] Univ Leipzig, Dept Med, Leipzig, Germany
[11] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany
[12] Univ Paris 06, Paris, France
[13] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany
基金
欧洲研究理事会;
关键词
HEPATIC LIPID-METABOLISM; MAMMALIAN TARGET; HEMOPHILIA-B; IN-VITRO; VIRUS; RAPAMYCIN; MTOR; TRANSDUCTION; DISEASES; CANCER;
D O I
10.1002/hep.29176
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Use of adeno-associated viral (AAV) vectors for liver-directed gene therapy has shown considerable success, particularly in patients with severe hemophilia B. However, the high vector doses required to reach therapeutic levels of transgene expression caused liver inflammation in some patients that selectively destroyed transduced hepatocytes. We hypothesized that such detrimental immune responses can be avoided by enhancing the efficacy of AAV vectors in hepatocytes. Because autophagy is a key liver response to environmental stresses, we characterized the impact of hepatic autophagy on AAV infection. We found that AAV induced mammalian target of rapamycin (mTOR)-dependent autophagy in human hepatocytes. This cell response was critically required for efficient transduction because under conditions of impaired autophagy (pharmacological inhibition, small interfering RNA knockdown of autophagic proteins, or suppression by food intake), recombinant AAV-mediated transgene expression was markedly reduced, both in vitro and in vivo. Taking advantage of this dependence, we employed pharmacological inducers of autophagy to increase the level of autophagy. This resulted in greatly improved transduction efficiency of AAV vectors in human and mouse hepatocytes independent of the transgene, driving promoter, or AAV serotype and was subsequently confirmed in vivo. Specifically, short-term treatment with a single dose of torin 1 significantly increased vector-mediated hepatic expression of erythropoietin in C57BL/6 mice. Similarly, coadministration of rapamycin with AAV vectors resulted in markedly enhanced expression of human acid-alpha-glucosidase in nonhuman primates. Conclusion: We identified autophagy as a pivotal cell response determining the efficiency of AAVs intracellular processing in hepatocytes and thus the outcome of liver-directed gene therapy using AAV vectors and showed in a proof-of-principle study how this virus-host interaction can be employed to enhance efficacy of this vector system.
引用
收藏
页码:252 / 265
页数:14
相关论文
共 50 条
  • [1] Evaluation of Adeno-Associated Viral Vectors for Liver-Directed Gene Transfer in Dogs
    Bell, Peter
    Gao, Guangping
    Haskins, Mark E.
    Wang, Lili
    Sleeper, Meg
    Wang, Huan
    Calcedo, Roberto
    Vandenberghe, Luk H.
    Chen, Shu-Jen
    Weisse, Chick
    Withnall, Elanor
    Wilson, James M.
    HUMAN GENE THERAPY, 2011, 22 (08) : 985 - 997
  • [2] Adeno-associated virus as a vector for liver-directed gene therapy
    Xiao, WD
    Berta, SC
    Lu, MM
    Moscioni, AD
    Tazelaar, J
    Wilson, JM
    JOURNAL OF VIROLOGY, 1998, 72 (12) : 10222 - 10226
  • [3] Adeno-Associated Viral Vectors for Gene Therapy
    Dalkara, Deniz
    OPHTHALMOLOGICA, 2014, 232 : 8 - 9
  • [4] Adeno-associated viral vectors for gene therapy
    Summerford, C
    Samulski, RJ
    BIOGENIC AMINES, 1998, 14 (05) : 451 - 475
  • [5] Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy
    Rodriguez-Marquez, Esther
    Meumann, Nadja
    Buening, Hildegard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (06) : 749 - 766
  • [6] A role for adeno-associated viral vectors in gene therapy
    Coura, Renata dos Santos
    Nardi, Nance Beyer
    GENETICS AND MOLECULAR BIOLOGY, 2008, 31 (01) : 1 - 11
  • [7] Deciphering conundrums of adeno-associated virus liver-directed gene therapy: focus on hemophilia
    Pierce, Glenn F.
    Fong, Sylvia
    Long, Brian R.
    Kaczmarek, Radoslaw
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (05) : 1263 - 1289
  • [8] Liver directed adeno-associated viral vectors to treat metabolic disease
    Chuecos, Marcel A.
    Lagor, William R.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2024, 47 (01) : 22 - 40
  • [9] Progress in the use of adeno-associated viral vectors for gene therapy
    Büning, H
    Braun-Falco, M
    Hallek, M
    CELLS TISSUES ORGANS, 2004, 177 (03) : 139 - 150
  • [10] Novel adeno-associated viral vectors for retinal gene therapy
    L H Vandenberghe
    A Auricchio
    Gene Therapy, 2012, 19 : 162 - 168